This Battlefield Protection Company Has Gone Nuclear. It's an Obvious Buy. -- Barrons.com

Dow Jones03-05

By Dan Victor

Geopolitical instability provides a compelling backdrop for defense sector investments. After all, war is big business. Yet for Cadre Holdings, the latest Middle East conflict is only one catalyst within a broader, multifaceted growth story.

The Jacksonville, Fla.-based company with a $1.9 billion market capitalization is a leader in the public safety supply chain. Its products include everything from holster and tactical duty belts to riot gear, ballistic armor, field communications systems, forensic testing kits, and explosive ordnance disposal robots. As its customers prioritize survivability and modernization of their equipment capabilities, Cadre has capitalized on being a one-stop shop for law enforcement, federal agencies, and U.S. and international allied armed forces operating in complex threat environments.

Its stock has proven to be an effective compounder, with its price more than doubling in the past three years. Increases in state and local police funding, along with an expansion effort into a new vertical servicing the nuclear industry, highlights its evolving growth tailwinds. It's currently trading near a record high, but there's plenty of room for more upside, whether the Iran conflict escalates or not.

In war or in peace, Cadre looks like a good bet for further gains in 2026 and beyond. In a scenario in which growth and margins outperform expectations, we think the stock can climb as high as $70, about a 55% upside from the recent price of $44.50.

The bullish view is shared by Michael Goodman, portfolio manager of the Cromwell Greenspring Mid Cap fund, which features Cadre among its holdings. "With high profitability and a culture of continuous improvement, Cadre generates robust free cash flow to fund organic growth and strategic acquisitions," he says, citing the company's balance sheet, insider ownership, and attractive stock valuation.

Recent operating and financial trends reinforce Cadre's strong fundamental profile. Ahead of its fourth-quarter earnings release, scheduled for March 10, the company expects full-year net sales of around $627 million, an annual increase of about 10% -- and a similar jump in annual adjusted earnings before interest tax, depreciation, and amortization, or Ebitda. Looking beyond that, Wall Street projects an even stronger outlook for 2026, with a building consensus for accelerating earnings as the company's global reach ramps up.

Part of the momentum reflects Cadre's increasingly high-tech offerings. Multiple acquisitions in recent years have diversified its sales mix while lifting margins. The company's most recent acquisition, TYR Tactical, provides a "significant entry into new markets, particularly European military and defense," Cadre President Brad Williams told a recent investor conference. TYR's hard armor pressing capabilities are a critical process for the manufacture of advanced antiballistic materials, including those used in protective gear designed to withstand armor-piercing rounds of the type soldiers might be exposed to in a war zone.

The TYR deal is expected to generate meaningful synergies and add 16% to earnings per share this year, according to Jefferies analyst Sheila Kahyaoglu. She estimates EPS could reach $1.59 in 2026, representing a roughly 25% increase from her 2025 adjusted earnings estimate of $1.18. In a note reaffirming a Buy rating on the stock, Kahyaoglu points to increased funding for state and local police protection, along with the company's international market share gains against smaller competitors. Her $55 price target implies a 24% upside.

Importantly, Cadre's potential is no longer confined to tactical gear. Through acquisitions such as Alpha Safety in 2024 and Carr's Engineering early last year, the company has strategically entered the nuclear handling and safety solutions business. Its abilities include containment and handling systems, nuclear waste management equipment, and radiological detection technologies.

In response to potential nuclear armed adversaries, the U.S. Department of Defense and National Nuclear Security Administration are moving to modernize the country's nuclear weapons capabilities, targeting the buildout of up to 80 war-reserve plutonium pits a year. These pits -- spherical cores the size of bowling balls that trigger the warhead -- have not been produced in the U.S. in nearly three decades, according to the Department of Energy. Cadre is now equipped to manage the extremely hazardous industrial process of storing, transporting, and monitoring these materials. It's a clear growth driver.

Outside the national security use cases, the nuclear industry is undergoing a renaissance fueled by renewed investment in nuclear power generation. Power requirements of artificial-intelligence data centers have kick-started plans for new nuclear power plants, while aging reactor fleets are expected to see their service life extended. Cadre can capture lucrative recurring contracts where technically complex projects and strict certifications serve as barriers to entry.

Shares of Cadre are currently trading at approximately 30 times its consensus year-ahead EPS -- a multiple that sits above the broader market but reasonable within its peer group. Competitors include Mirion Technologies, trading at 37 times earnings, and Axon Enterprise, which commands a 68-times earnings multiple. Axon's premium reflects its near monopoly on products like body cams and nonlethal tasers. Nevertheless, Cadre's diversification is unmatched, with its valuation justified based on its strong outlook and history of execution.

With a roughly $2 billion serviceable addressable market in the core law-enforcement personal protective equipment business, its Nuclear Group has opened the door for an additional $3 billion to $6 billion opportunity. If management continues integrating acquisitions effectively while driving operating leverage and consolidating its leadership role, earnings growth should outpace revenue -- a combination that can sustain elevated valuation multiples and propel the stock higher over the long run.

As intriguing as the outlook might seem, the investment isn't entirely risk-free. Revenue is largely dependent on government budgets, where procurement cycles can be bumpy, particularly against high expectations. The current geopolitical and political climate also introduces a layer of uncertainty, where shifting sentiment toward the wider defense sector could pressure the stock even if financials remain intact.

Ultimately, the upside here is worth it. For investors willing to look beyond near-term headlines, Cadre stands out as a differentiated small-cap stock with a structurally growing platform where scale, technical expertise, and disciplined capital allocations could continue to translate into outsize shareholder returns.

   -- Stay tuned for the next live Q&A! Watch the Barron's Investor Circle page 
      for the sign-up link 
 
   -- Share your questions and thoughts in the "Conversation" section below to 
      engage directly with the author and our community 
 
   -- Receive alerts about more content from this author by clicking "Follow" 
      next to the author byline at top 

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 05, 2026 08:00 ET (13:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment